Mobilization and mechanism of transcription of integrated self-inactivating lentiviral vectors

Journal of Virology

Volumn 79, Issue 13, 2005, Pages 8410-8421

  Hanawa, Hideki ^a   Persons, Derek A ^a   Nienhuis, Arthur W ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN;

ARTICLE; CELL LINE; CHROMATIN STRUCTURE; CONTROLLED STUDY; DNA MODIFICATION; DRUG SENSITIVITY; EMBRYO; ENHANCER REGION; GENE ACTIVATION; GENE DISRUPTION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LONG TERMINAL REPEAT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REGULATOR GENE; SAFETY; VIRUS DNA CELL DNA INTERACTION; VIRUS GENOME; VIRUS INACTIVATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ANIMALS; BASE SEQUENCE; DNA PRIMERS; ENHANCER ELEMENTS (GENETICS); GENES, REPORTER; GREEN FLUORESCENT PROTEINS; LENTIVIRUS; PLASMIDS; PROMOTER REGIONS (GENETICS); RNA, VIRAL; SEQUENCE DELETION; TERMINAL REPEAT SEQUENCES; TRANSCRIPTION, GENETIC; VIRUS INTEGRATION;

EID: 20744453655     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.13.8410-8421.2005     Document Type: Article

References (53)

1. Ailles, L. E., and L. Naldini. 2002. HIV-1-derived lentiviral vectors. Curr. Top. Microbiol. Immunol. 261:31-52.
2. Allan, M., W. G. Lanyon, and J. Paul. 1983. Multiple origins of transcription in the 4.5 kb upstream of the epsilon-globin gene. Cell 35:187-197.
3. Chen, W. V., J. Delrow, P. D. Corrin, J. P. Frazier, and P. Soriano. 2004. Identification and validation of PDGF transcriptional targets by microarray-coupled gene-trap mutagenesis. Nat. Genet. 36:304-312.
4. Evans, J. T., and J. V. Garcia. 2000. Lentivirus vector mobilization and spread by human immunodeficiency virus. Hum. Gene Ther. 11:2331-2339.
5. Flint, S. J., L. W. Enquist, R. M. Krug, V. R. Racaniello, and A. M. Skaika (ed.) 2000. Principles of virology: molecular biology, pathogenesis, and control. ASM Press, Washington, D.C.
6. Follenzi, A., M. Battaglia, A. Lombarde, A. Annoni, M. G. Roncarolo, and L. Naldini. 2004. Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice. Blood 103:3700-3709.
7. Gribnau, J., K. Diderich, S. Pruzina, R. Calzolari, and P. Fraser. 2000. Intergenic transcription and developmental remodeling of chromatin subdomains in the human beta-globin locus. Mol. Cell 5:377-386.
8. Grindlay, G. J., W. G. Lanyon, M. Allan, and J. Paul. 1984. Alternative sites of transcription initiation upstream of the canonical cap site in human gamma-globin and beta-globin genes. Nucleic Acids Res. 12:1811-1820.
9. Grunwald, T., F. S. Pedersen, R. Wagner, and K. Uberla. 2004. Reducing mobilization of simian immunodeficiency virus based vectors by primer complementation. J. Gene Med. 6:147-154.
10. + cells with HIV-1-derived lentiviral vectors. Mol. Ther. 2:71-80.
11. Hacein-Bey-Abina, S., C. Von Kalle, M. Schmidt, M. P. McCormack, N. Wulffraat, P. Leboulch, A. Lim, C. S. Osborne, R. Pawliuk, E. Morillon, R. Sorensen, A. Forster, P. Fraser, J. I. Cohen, G. de Saint Basile, I. Alexander, U. Wintergerst, T. Frebourg, A. Aurias, D. Stoppa-Lyonnet, S. Romana, I. Radford-Weiss, F. Gross, F. Valensi, E. Delabesse, E. Macintyre, F. Sigaux, J. Soulier, L. E. Leiva, M. Wissler, C. Prinz, T. H. Rabbitts, F. Le Deist, A. Fischer, and M. Cavazzana-Calvo. 2003. LMO2-associated clonal T cell proliferation in two patients after gene therapy SCID-X1. Science 302:415-419.
12. Han, B., and J. T. Zhang. 2002. Regulation of gene expression by internal ribosome entry sites or cryptic promoters: the eIF4G story. Mol. Cell. Biol. 22:7372-7384.
13. Hanawa, H., P. Hemmatti, K. Keyvanfar, M. E. Metzger, A. Krouse, R. E. Donahue, S. Kepes, J. Gray, C. E. Dunbar, D. A. Persons, and A. W. Nienhuis. 2004. Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus-based lentiviral vector system. Blood 103:4062-4069.
14. Hanawa, H., P. F. Kelly, A. C. Nathwani, D. A. Persons, J. A. Vandergriff, P. Hargrove, E. F. Vanin, and A. W. Nienhuis. 2002. Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood. Mol. Ther. 5:242-251.
15. Hargrove, P. W., H. Hanawa, S. Kepes, C. Cheng, G. Neale, A. W. Nienhuis, and D. A. Persons. 2004. Assessment of changes in gene expression caused by insertions of a globin lentiviral vector containing globin regulatory elements or a lentiviral vector containing retroviral LTR elements. Blood. 104(Suppl. I):145a.
16. Hawley, R. G., F. H. Lieu, A. Z. Fong, and T. S. Hawley. 1994. Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1:136-138.
17. Hematti, P., B. K. Hong, C. Ferguson, R. Adler, H. Hanawa, S. Sellers, I. E. Holt, C. E. Eckfeldt, Y. Sharma, M. Schmidt, C. von Kalle, D. A. Persons, E. M. Billings, C. M. Verfaillie, A. W. Nienhuis, T. G. Wolfsberg, C. E. Dunbar, and B. Calmels. 2004. Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells. PLoS Biol. 2:2183-2190.
18. Herman, J. G., and S. B. Baylin. 2003. Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 349:2042-2054.
19. Kafri, T., U. Blomer, D. A. Peterson, F. H. Gage, and I. M. Verma. 1997. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat. Genet. 17:314-317.
20. Kamyo, T., S. Bodner, E. van de Kamp, D. H. Randle, and C. J. Sherr. 1999. Tumor spectrum in ARF-defkient mice. Cancer Res. 59:2217-2222.
21. Kaplan, C. D., L. Laprade, and F. Winston. 2003. Transcription elongation factors repress transcription initiation from cryptic sites. Science 301:1096-1099.
22. Kappes, J. C., X. Wu, and J. K. Wakefield. 2003. Production of translentiviral vector with predictable safety. Methods Mol. Med. 76:449-465.
23. Khorasanizadeh, S. 2004. The nucleosome: from genomic organization to genomic regulation. Cell 116:259-272.
24. Lai, Z., I. Han, M. Park, and R. O. Brady. 2002. Design of an HIV-1 lentiviral-based gene-trap vector to detect developmentally regulated genes in mammalian cells. Proc. Natl. Acad. Sci. USA 99:3651-3656.
25. Ley, T. J., and A. W. Nienhuis. 1983. A weak upstream promoter gives rise to long human beta-globin RNA molecules. Biochem. Biophys. Res. Commun. 112:1041-1048.
26. Logan, A. C., D. L. Haas, T. Kafri, and D. B. Kohn. 2004. Integrated self-inactivating lentiviral vectors produce full-length genomic transcripts competent for encapsidation and integration. J. Virol. 78:8421-8436.
27. Logan, A. C., C. Lutzko, and D. B. Kohn. 2002. Advances in lentiviral vector designs for gene-modification of hematopoietic stem cells. Curr. Opin. Biotechnol. 13:429-436.
28. Manley, N. R., M. O'Connell, W. Sun, N. A. Speck, and N. Hopkins. 1993. Two factors that bind to highly conserved sequences in mammalian type C retroviral enhancers. J. Virol. 67:1967-1975.
29. Medico, E., G. Gambarotta, A. Gentile, P. M. Comoglio, and P. Soriano. 2001. A gene trap vector system for identifying transcriptionally responsive genes. Nat. Biotechnol. 19:579-582.
30. Miyoshi, H., U. Blomer, M. Takahashi, F. H. Gage, and I. M. Verma. 1998. Development of a self-inactivating lentivirus vector. J. Virol. 72:8150-8157.
31. Mizushima, S., and S. Nagata. 1990. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 18:5322.
32. Naldini, L., U. Blomer, F. H. Gage, D. Trono, and I. M. Verma. 1996. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA 93:11382-11388.
33. Naldini, L., U. Blomer, P. Gallay, D. Ory, R. Mulligan, F. H. Gage, I. M. Verma, and D. Trono. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
34. Olsen, J. C. 2001. EIAV, CAEV and other lentivirus vector systems. Somat. Cell Mol. Genet. 26:131-145.
35. O'Rourke, J. P., G. C. Newbound, D. B. Kohn, J. C. Olsen, and B. A. Bunnell. 2002. Comparison of gene transfer efficiencies and gene expression levels achieve with equine anemia virus- and human immunodeficiency virus type-1-derived lentivirus vectors. J. Virol. 76:1510-1515.
36. Poeschla, E. M. 2003. Non-primate lentiviral vectors. Curr. Opin. Mol. Ther. 5:529-540.
37. Recillas-Targa, F., M. J. Pikkart, B. Burgess-Beusse, A. C. Bell, M. D. Litt, A. G. West, M. Gaszner, and G. Felsenfeld. 2002. Position-effect protection and enhancer blocking by the chicken beta-globin are separable activities. Proc. Natl. Acad. Sci. USA 99:6883-6888.
38. Ruggieri, A., D. Negre, and F. L. Cosset. 2003. SIV vectors. Methods Mol. Biol. 229:233-249.
39. Sastry, L., T. Johnson, M. J. Hobson, B. Smucker, and K. Cornetta. 2002. Tittering lentiviral vectors: comparison of DNA, RNA and marker expression methods. Gene Ther. 9:1155-1162.
40. Sastry, L., Y. Xu, T. Johnson, K. Desai, D. Rissing, J. Marsh, and K. Cornetta. 2003. Certification assays for HIV-1-based vectors: frequent passage of gag sequences without evidence of replication-competent viruses. Mol. Ther. 8:830-839.
41. Schek, N., C. Cooke, and J. C. Alwine. 1992. Definition of the upstream efficiency element of the simian virus 40 late polyadenylation signal by using in vitro analyses. Mol. Cell. Biol. 12:5386-5393.
42. Schnell, T., P. Foley, M. Wirth, J. Munch, and K. Uberla. 2000. Development of a self-inactivating, minimal lentivirus vector based on simian immunodeficiency virus. Hum. Gene Ther. 11:439-447.
43. Schroder, A. R., P. Shinn, H. Chen, C. Berry, J. R. Ecker, and F. Bushman. 2002. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110:521-529.
44. Sorrentino, B. P., and A. W. Nienhuis. 2001. Gene therapy for hematopoietic diseases, p. 969-1003. In G. Stamatoyannopoulos, P. W. Majerus, R. M. Perlmutter, H. Varmus (ed.), The molecular basis of blood diseases, 3rd ed. W.B. Saunders Company, Philadelphia, Pa.
45. Takahashi, M. 2004. Delivery of genes to the eye using lentiviral vectors. Methods Mol. Biol. 246:439-449.
46. Telesnitsky, A., and S. P. Goff. 1997. Reverse transcription and the generation of retroviral RNA, p. 121-160. In J. M. Coffin, S. H. Hughes, and H. E. Varmus (ed.), Retroviruses. Cold Spring Harbor Press, Woodbury, N.Y.
47. Uetsuki, T., A. Naito, S. Nagata, and Y. Kaziro. 1989. Isolation and characterization of the human chromosomal gene for polypeptide chain elongation factor-1 alpha. J. Biol. Chem. 264:5791-5798.
48. Westerman, K. A., T. Morales, R. Pawliuk, E. Cohen, and P. LeBoulch. 2003. A high titer, "supersplit" packaging system in combination with a self-inactivating (SIN) vector for the prevention of replication competent lentivirus (RCL) contamination. Mol. Ther. 7:S3.
49. Wong, L. F., M. Azzouz, L. E. Walmsley, Z. Askham, F. J. Wilkes, K. A. Mitrophanous, S. M. Kingsman, and N. D. Mazarakis. 2004. Transduction patterns of pseudotyped lentiviral vectors in the nervous system. Mol. Ther. 9:101-111.
50. Wu, X., Y. Li, B. Crise, and S. M. Burgess. 2003. Transcription start regions in the human genome are favored targets for MLV integration. Science 13:1749-1751.
51. Wu, X., J. K. Wakefield, H. Liu, H. Xiao, R. Kralovics, J. T. Prchal, and J. C. Kappes. 2000. Development of a novel trans-lentiviral vector that affords predictable safety. Mol. Ther. 2:47-55.
52. Xu, K., H. Ma, T. J. McCown, I. M. Verma, and T. Kafri. 2001. Generation of a stable cell line producing high-liter self-inactivating lentiviral vectors. Mol. Ther. 3:97-104.
53. Zufferey, R., T. Dull, R. J. Mandel, A. Bukovsky, D. Quiroz, L. Naldini, and D. Trono. 1998. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 72:9873-9880.